Convatec Group Plc Stock Today
| CNVVF Stock | USD 2.95 0.10 3.51% |
Performance0 of 100
| Odds Of DistressLess than 9
|
ConvaTec Group is trading at 2.95 as of the 27th of November 2024. This is a 3.51 percent increase since the beginning of the trading day. The stock's lowest day price was 2.95. ConvaTec Group has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for ConvaTec Group Plc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. The company was founded in 1978 and is headquartered in Reading, the United Kingdom. Convatec Group operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. The company has 2.04 B outstanding shares. More on ConvaTec Group Plc
Moving against ConvaTec Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ConvaTec Pink Sheet Highlights
| President | Supratim Bose |
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
ConvaTec Group Plc [CNVVF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.85 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ConvaTec Group's market, we take the total number of its shares issued and multiply it by ConvaTec Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ConvaTec Group Plc classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 2.04 B outstanding shares.
ConvaTec Group Plc has accumulated about 463.4 M in cash with 305.9 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check ConvaTec Group Probability Of Bankruptcy
Ownership AllocationConvaTec Group holds a total of 2.04 Billion outstanding shares. Over half of ConvaTec Group's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ConvaTec Ownership Details
ConvaTec Group Plc Risk Profiles
| Mean Deviation | 0.8666 | |||
| Standard Deviation | 4.03 | |||
| Variance | 16.21 | |||
| Risk Adjusted Performance | 0.0084 |
ConvaTec Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ConvaTec Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
ConvaTec Group Corporate Management
| Karim Bitar | CEO Director | Profile | |
| Natalia Kozmina | Ex Officer | Profile | |
| Mark Reynolds | Director Relations | Profile | |
| Jonathan Mason | Group Director | Profile |
Other Information on Investing in ConvaTec Pink Sheet
ConvaTec Group financial ratios help investors to determine whether ConvaTec Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ConvaTec with respect to the benefits of owning ConvaTec Group security.